We are the #1 nonprofit biotechnology organization dedicated to developing effective
treatments for ALS.
At TDI, we have one urgently important goal: to end ALS. We envision a future where
patients no longer die from ALS and where today's patients are alive, well, and
enjoying the company of their children and grandchildren.
We are committed to creating and leading a transparent collaborative research process
that involves ALS patients today and honors those whose journey with this disease
has ended. We are guided by passion, love and the spirit of entrepreneurship upon
which we were founded.
In a word: unbiased. We'll take answers anywhere we find them. We're curious, creative,
and willing to follow any promising lead.
Learn more about our research >
Yes there's a plan. Our President & CEO, Dr. Steve Perrin, talks about how we work
and what makes us the #1 ALS research lab in the world.
Find out more about our plan >
ALS Today Magazine is an independent interactive news magazine featuring the latest research
advances and potential therapies for ALS/MND. Published by ALS TDI, ALS Today informs
clinicians, research scientists, patients and care providers about global efforts
to end ALS. Read ALS Today Magazine >
Find out what we've been up to since 1999.
Read Our History >
Who's who at TDI.
Meet TDI Super Heros >
Meet our current board members.
Meet Our Board >
TDI by the numbers.
Read Our Reports >
Want a job that really matters?
See what openings are available at TDI. >